glp 1 impact on bariatric surgery GLP1 After Surgery: What Every Patient Should Know Metabolic and bariatric surgery versus

NAION = non-arteritic anterior ischemic optic neuropathy is a rare cause of blindness and has been reported at higher rates in those taking GLP1s

(WROC) Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs used to treat certain medical conditions remain cove...

In earlier studies, retatrutide reduced liver fat by more than 80% in people with metabolic fatty liver disease, with most participants no longer meeting diagnostic thresholds

Primary outcomes included changes in TTR, INR, and INR recheck frequency

doi: 10.1097/TP.0000000000005496.

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety